- Documenting and standardizing all the product specifications and assembly procedures. - Assist in the development of the website

Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company’s proprietary AccuCinch® Ventricular Restoration System is the first completely percutaneous device designed to restore the enlarged left ventricle of the heart, thereby addressing the fundamental issue in the progression of systolic heart failure. It has come to our attention that an unknown entity is impersonating our organization and extending illegitimate job offers via email, purportedly in an attempt to defraud intended applicants. Please be advised that these email solicitations appear to be part of a fake job scheme. For additional information, please see https://www.fbi.gov/contact-us/field-offices/elpaso/news/press-releases/fbi-warns-cyber-criminals-are-using-fake-job-listings-to-target-applicants-personally-identifiable-information. Authorized Ancora Heart employees will reach out to potential candidates directly via telephone or email from ancoraheart.com but will never issue questionnaires or request personal information. Job offers will only be extended after a thorough interview process and multiple interactions with Ancora Heart staff members. When communicating, please be very cautious of fictitious email addresses.

EXPLORAMED NC7, INC is a medical devices company based out of 2570 W EL CAMINO REAL, Mountain View, California, United States.

BAY AREA INDUSTRIAL FILTRATION, INC. is a company based out of 6355 COLISEUM WAY, OAKLAND, California, United States.

Here in the middle of Silicon Valley, Avantec counts with the best talent from one of the brightest and most diverse candidate pools to develop the latest in industry leading cardiovascular, neurovascular and peripheral vascular medical devices. Avantec strives to continuously advance innovative devices that address unmet clinical needs. Avantec plays a key role in the corporate global business development endeavor, employing our core strength in technology and product development to pursue new opportunities in satisfying unmet clinical needs. Future technology development and product pipelines. - Vascular Retrieval System - Neurovascular / peripheral coils - Peripheral Atherectomy - Specialty coronary / peripheral DES

Established in 1978 by Carlo Di Ruocco, Mr. Espresso is a specialty coffee roasting company that has stayed true to their Italian roots and culture as the first and only U.S. coffee company to use a traditional wood-roasting method. This technique results in high moisture content and an increased retention of natural oils, producing a complex and full-bodied espresso with less acidity. Mr. Espresso features a lineup of single origin coffees, espresso blends, and house blends with organic and fair trade options, as well as several decaffeinated blends. In addition to its premium coffees, Mr. Espresso also hosts a large variety of imported espresso equipment for sale from top Italian manufacturers such as Mazzer and Macap, and as the exclusive distributor of Faema espresso machines in Northern California, Oregon, Washington, Nevada and Hawaii. All machines are UL and NSF standard approved. Offering wholesale beans, high-quality espresso equipment, and service and training support, Mr. Espresso made its mark as one of the first full-service coffee roasting retailers in the market and has since become a Bay Area institution, serving a sizable share of coffeehouses and restaurants in San Francisco Bay area and beyond. Mr. Espresso continues to be family-owned and operated with two generations of Di Ruoccos working together in the Oakland showroom and roasting facility to ensure that what Carlo Di Ruocco began over 30 years ago continues striking that wonderful balance between time-honored traditional methods and the emerging trends of the marketplace.

ARK Diagnostics Inc. designs, manufactures, and distributes in vitro diagnostic products. ARK’s proprietary assays accurately measure drug levels in biological fluids. Clinicians use these measurements to guide dosing decisions for safe, effective, and personalized drug therapy. By optimizing drug levels, clinicians improve outcomes, reduce toxicity, and lower healthcare costs. ARK is dedicated to improving the quality of patient health through better therapeutic drug management. (ARK Diagnostics, Inc. seeks regulatory clearance in the United States and Internationally.)

Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale Subscribe to our newsletter: http://eepurl.com/huCdiH

Interson Corporation is the medical device industry leader in ultrasound imaging devices since 1989. For almost 30 years in the Silicon Valley, Interson has been specializing in the design, manufacturing, sales and service of cutting-edge ultrasound imaging technology for both medical and veterinary diagnostic applications. In 2007, Interson was the first medical device company to introduce the revolutionary point-of-care USB-based portable/handheld imaging device that connects to any PC laptop or tablet. With this constant focus on innovation, Interson continues to strive towards providing a more accessible and reliable medical diagnostic healthcare solution to the global medical community. Interson’s mission is to make medical diagnostic tools available for the rest of us via THE POWER TO SEE. Addressing specific needs of the medical community by leveraging improving technologies, Interson will continue to support the medical community with both affordable and reliable diagnostic imaging solutions.

Implantable Shock Absorbers for Knee OA

Broncus Medical, Inc. is a well-funded, commercial stage company based in San Jose, CA. The Company’s mission is to deliver navigation, diagnostic & therapeutic technologies to treat patients with lung disease. The Company has a comprehensive intellectual property portfolio with ~75 patents including those issued, licensed, and pending. Along with Broncus Medical’s focus on technological advancements, it is committed to providing outstanding value to patients, medical professionals, investors and employees. Broncus Medical has commercialized and continues to develop innovative solutions for diagnosing and treating lung diseases. Physicians use LungPoint® Virtual Bronchoscopic Navigation Systems to plan bronchoscopic procedures and quickly and accurately maneuver to tumors in the lungs. LungPoint is a powerful platform for computer-assisted, image-guided bronchoscopic planning and navigation that is intuitive and easy to use. It provides a map and visual directions through the lung airways to a lung tumor. The unique 18 gauge FleXNeedle® coring needle enables peripheral sampling and access to hard-to-reach areas of the lungs. Now Broncus has developed Archimedes™ total lung access platform, including BTPNA - Bronchoscopic Trans-Parenchymal Nodule Access. The Archimedes System combines state-of-the-art nodule, vessel and airway mapping, pathway guidance and intra-operative fluoroscopy imaging - allowing never before biopsy and therapeutic access to any spot in the lung.